Evidence map›Paper›PMID 39679738›Full record

ArticleBiometrics2024

Adaptive randomization methods for sequential multiple assignment randomized trials (smarts) via thompson sampling.

Peter Norwood, Marie Davidian, Eric Laber

Abstract read
In one paragraph

Article in Biometrics, 2024. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.

0numbers the graph read from it
0cells of the map it votes in
1citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

1 citing paper in PubMed.

  1. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

3 authors.

Peter NorwoodQuantum Leap Healthcare Collaborative, 499 Illinois Ave, Suite 200, San Francisco, CA 94158, United States.
Marie DavidianDepartment of Statistics, North Carolina State University, 2311 Stinson Drive, Campus Box 8203, Raleigh, NC 27695-8203, United States.ORCID 0000-0002-9202-6341
Eric LaberDepartment of Statistical Science, Duke University, 214 Old Chemistry, Box 90251, Durham, NC 27708-0251, United States.

Funding

Next-generation SMARTs for Discovery and Evaluation of Sequential Cancer Therapeutic StrategiesR01CA280970 · NCI · DUKE UNIVERSITY · PI Eric Benjamin Laber · 2024 to 2026
$1.1M
NCI NIH HHS R01 CA280970NIH HHS R01CA280970
6 · The paper itself

Abstract

Response-adaptive randomization (RAR) has been studied extensively in conventional, single-stage clinical trials, where it has been shown to yield ethical and statistical benefits, especially in trials with many treatment arms. However, RAR and its potential benefits are understudied in sequential multiple assignment randomized trials (SMARTs), which are the gold-standard trial design for evaluation of multi-stage treatment regimes. We propose a suite of RAR algorithms for SMARTs based on Thompson Sampling (TS), a widely used RAR method in single-stage trials in which treatment randomization probabilities are aligned with the estimated probability that the treatment is optimal. We focus on two common objectives in SMARTs: (1) comparison of the regimes embedded in the trial and (2) estimation of an optimal embedded regime. We develop valid post-study inferential procedures for treatment regimes under the proposed algorithms. This is nontrivial, as even in single-stage settings standard estimators of an average treatment effect can have nonnormal asymptotic behavior under RAR. Our algorithms are the first for RAR in multi-stage trials that account for non-standard limiting behavior due to RAR. Empirical studies based on real-world SMARTs show that TS can improve in-trial subject outcomes without sacrificing efficiency for post-trial comparisons.

Indexed as

AlgorithmsRandomized Controlled Trials as TopicBiometryComputer SimulationData Interpretation, StatisticalHumansModels, StatisticalRandom AllocationResearch Designinverse probability weighted estimatorprecision medicineresponse-adaptive randomization, treatment regime

Identifiers

PMID39679738
PMCPMC11647911

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.